[RAF Kinase Inhibitor Protein Expression in Diabetes]
by
ACKNOWLEDGEMENT
I would take this opportunity to thank my research supervisor, family and friends for their support and guidance without which this research would not have been possible.
DECLARATION
I, [type your full first names and surname here], declare that the contents of this dissertation/thesis represent my own unaided work, and that the dissertation/thesis has not previously been submitted for academic examination towards any qualification. Furthermore, it represents my own opinions and not necessarily those of the University.
Signed __________________ Date _________________
ABSTRACT
Raf kinase inhibitor protein (RKIP) is a member of the PhosphatidylEthanolamine-Binding Protein (PEBP) family. It was originally described as an inhibitor of Ras/Raf/MEK/ERK pathway. Dysregulation of RKIP expression has the potential to contribute to pathophysiological processes including Alzheimer's disease and several types of cancer. It has been believed that oxidative stress plays a role in the pathogenesis in a variety of diseases including cancer and diabetes mellitus. Recently, one study found knocking down RKIP gene in immortalized cell line increased the oxidative stress.
This study is aimed to investigate the expression of RKIP in diabetes mellitus. Diabetic Goto-Kakizaki (GK) rats were used as a model for type 2 diabetes and diabetic Streptozotosin (STZ) rats were used as model for type 1 diabetes. All experimental rats were wounded surgically and left to heal for 7 days. Different tissues (liver, kidney, heart and wounded skin) were removed from all experimental rats. Various oxidative damage markers (dihydroethidium, DNPH, lipid peroxidation) and antioxidant enzymes (catalase, SOD, GSH) were used to verify the status of oxidative stress. RKIP expression was determined by western blot and immunofluorescent assay.
The results showed significant increase in the level of oxidative stress (p<0.05) in all tissues derived from both types of diabetic rats compared to non-diabetic controls. RKIP expression was significantly decreased in all tissues derived from diabetic-GK rats (p<0.05) compared to those of non-diabetic control rats. Meanwhile, diabetic-STZ rats showed no change in the expression of RKIP
RKIP expression is clearly decreased in type 2 diabetic model while it has no change in type 1 diabetic model. Oxidative stress appears to have no effect on the expression of RKIP indicating that RKIP in diabetes may not be associated with oxidative stress.
TABLE OF CONTENTS
ACKNOWLEDGEMENT2
DECLARATION3
ABSTRACT4
CHAPTER 1: INTRODUCTION6
Raf Kinase Inhibitor Protein (RKIP)6
RKIP Functions8
RKIP and the MAPK Pathway8
RKIP and G-protein Coupled Receptor Signaling10
RKIP and NF?B Signaling12
RKIP and the Cell Cycle13
RKIP in Cancer14
RKIP in other cellular processes15
Diabetes15
Diabetes mellitus16
Primary (idiopathic) diabetes mellitus17
Type I Diabetes Mellitus17
Type II diabetes18
Secondary Diabetes Mellitus18
Complications of Diabetes Mellitus19
Metabolic Disturbances In Diabetes Mellitus19
Oxidative stress21
Oxidative Stress Chemistry22
Superoxide radical (O2-.)23
Hydrogen peroxide (H2O2)23
Nitric Oxide (NO)23
Hydroxyl radicals (OH.)24
Cellular Antioxidant Defense24
Dietary Antioxidants25
Reduced Glutathione (GSH)25
Antioxidant Enzymes26
Implications of oxidative stress26
Lipid peroxidation26
Oxidative DNA damage27
Oxidative damage to protein28
CHAPTER 2: HYPOTHESIS AND OBJECTIVES29
Hypothesis29
Objectives29
CHAPTER 3: MATERIALS AND METHODS30
Materials30
Chemicals30
Kits and Assay Solutions30
Antibodies30
Consumables30
Instruments31
Methods31
Experimental animals31
Diabetic Streprtozotocin (STZ) rats- type I Diabetes Mellitus32
Diabetic Goto-Kakizaki (GK) rats- type II Diabetes Mellitus32